Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies.
Jaggers
James
J
Department of Pediatric Cardiothoracic Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA. Jagge003@mc.duke.edu
Lawson
Jeffrey H
JH
D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D052158:Aptamers, Peptide / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D001779:Blood Coagulation Factors / Q000502:physiology; D016913:Blood Component Transfusion; D001803:Blood Transfusion; D002315:Cardiopulmonary Bypass / Q000009:adverse effects* / Q000295:instrumentation; D020099:Coated Materials, Biocompatible; D004730:Endothelium, Vascular / Q000503:physiopathology; D005167:Factor VII / Q000627:therapeutic use; D015942:Factor VIIa; D065427:Factor Xa Inhibitors; D006330:Heart Defects, Congenital / Q000601:surgery*; D006487:Hemostasis / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018836:Inflammation Mediators / Q000502:physiology; D011183:Postoperative Complications / Q000209:etiology* / Q000503:physiopathology; D011994:Recombinant Proteins / Q000627:therapeutic use; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use; D018746:Systemic Inflammatory Response Syndrome / Q000209:etiology* / Q000503:physiopathology; D010975:Platelet Aggregation Inhibitors
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D052158:Aptamers, Peptide; D001779:Blood Coagulation Factors; D020099:Coated Materials, Biocompatible; D065427:Factor Xa Inhibitors; D018836:Inflammation Mediators; D011994:Recombinant Proteins; D015842:Serine Proteinase Inhibitors; D005167:Factor VII; D007611:Aprotinin; C103587:recombinant FVIIa; D015942:Factor VIIa; D010975:Platelet Aggregation Inhibitors